Invesaro

Stocks PERI Financial statements

Financial statements

Perion Network Ltd. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Perion Network Ltd. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue313274253261328478640743498440
Cost of revenue25.924.723.825.5
Gross profit287249229236
Research and development25.217.218.922.630.935.334.633.936.734.7
Selling and marketing54.652.738.934.739.153.257.459.368.576.5
General and administrative28.821.916.51515.823.227.732.138.736.4
Operating expenses301350238243316433533629501455
Operating income11.3-75.714.71812.345.9107114-3.04-14.9
Interest expense5.314.793.942.331.05
Interest income0.20.130.30.620.290.544.9920.71912.9
Other non-operating income-8.29-5.92-3.79-3.47-2.64-0.584.52118.59.93
Pre-tax income3.06-81.610.914.59.6245.311213515.5-4.97
Income tax0.21-8.832.781.65-0.616.6114.420.32.872.96
Income from continuing operations2.85-72.88.1212.910.238.797.511512.6-7.93
Net income0.2-72.88.1212.910.238.797.511512.6-7.93
EBITDA37.3-59.124.427.722.255.812112813.42.78
EPS, basic0.01-2.810.310.500.381.132.172.440.27-0.19
EPS, diluted0.01-2.810.310.490.361.022.032.300.25-0.19
Shares, basic (weighted)25.525.825.92626.734.444.947.147.342.1
Shares, diluted (weighted)25.625.825.926.428.837.848.150.149.642.1

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents2431.639.138.447.710417618815690
Short-term investments8.415.91423.212.7217253207139151
Receivables71.362.855.649.181.2115160232164188
Other current assets10143.533.174.568.08122122.617.8
Total current assets114114104115147446603727561520
Property, plant and equipment14.217.515.610.96.774.213.613.188.9211.7
Lease right-of-use assets25.822.420.311.610.16.6120.217.2
Goodwill191125125126152189196248247266
Intangible assets4411.36.52.6424.456.751.788.768.989.2
Other non-current assets1.621.130.940.710.50.080.050.090.420.62
Total assets3682742562843597138701,077916914
Accounts payable38.339.238.247.772.5108156217122130
Accrued liabilities17.517.817.218.421.240.337.942.632.837.8
Deferred revenue5.355.273.794.195.713.852.382.32.051.21
Short-term debt17.91416.18.338.330
Total current liabilities86.781.477.183.3120194235340162189
Long-term debt8.33
Lease liabilities20.417.79.777.583.4518.720
Other non-current liabilities5.727.616.166.596.719.5411.815.612.111.4
Total liabilities160136108119175246287359193238
Total debt8.33
Paid-in capital235237240243252496514535527488
Retained earnings-25.6-98.4-90.3-77.4-67.1-28.470.8184197189
Treasury stock-1-1-1-1-1-1-1-1-1-1
Other comprehensive income-0.270.530.140.130.11-0.13-0.58-0.08-0.220.27
Shareholders' equity208138149165184467583718723676
Total equity208138149165184467583718723676
Total liabilities and equity3682742562843597138701,077916914
Shares outstanding77.225.925.926.227.443.746.24844.839

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income0.2-72.88.1212.910.238.797.511512.6-7.93
Depreciation and amortization2616.69.729.719.929.913.814.116.417.7
Stock-based compensation6.842.112.722.294.456.9913.31827.231.1
Deferred income tax-3.27-8.860.46-2.04-3.11-2.76-1.53-0.73-2.15-1.51
Change in receivables-5.338.897.426.42-32-34.2-45.2-5.3366.1-23
Cash from operations30.53632.844.722.271.11221556.9441.9
Capital expenditures-1.5-1.61-2.04-1.21-0.46-0.63-1.06-0.81-6.87-3.8
Acquisitions-29.5-2.55-3.33-1.2-19-38.4-9.57-1020-26.6
Purchases of investments-12.700-111-39.5-59.3
Sales and maturities of investments0034.440.865.9
Cash from investing28.1-4.85-1.82-21.2-8.92-243-46.8-13362.6-37.4
Debt issued525
Debt repaid00-0.45
Stock issued001.234.296.95.832.430.550.61
Cash from financing-52.6-23.8-23-24.8-4.05229-3.26-10.8-101-71.1
Exchange rate effect0.08-0.03-0.060.14-0.210.33
Net change in cash9.137.618.05-1.29.2756.77211.4-31.6-66.2
Free cash flow2934.430.843.521.770.51211550.0738.1
Interest paid5.684.623.572.321.10.20.010.010.010.09
Income taxes paid3.982.71.264.013.184.377.691813.18.35

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $8.59 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Operating margin-3.4%Operating income / revenue.
EBITDA margin0.6%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin-1.1%Pre-tax income / revenue.
Net margin-1.8%Net income / revenue.
FCF margin8.7%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin9.5%Cash from operations / revenue.
Return on equity (ROE)-1.1%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-0.9%Net income / average total assets.
Return on invested capital (ROIC)-2.0%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue7.9%Research and development expense / revenue.
Stock-based pay / revenue7.1%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue0.9%Capital expenditures / revenue.
D&A / revenue4.0%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y-11.7%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-11.8%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y6.0%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y-79.3%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y-71.6%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y-34.0%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y-162.9%Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y-176.0%EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y504.2%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y-30.0%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y13.6%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y56,806.0%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y-32.0%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y11.9%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y-6.5%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y5.0%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y29.7%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y-0.2%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y1.6%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y20.6%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-15.0%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-4.3%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y7.9%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio2.76xCurrent assets / current liabilities.
Quick ratio2.27x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio1.28x(Cash + short-term investments) / current liabilities.
Liabilities / assets26.0%Total liabilities / total assets.
Working capital$331.2MCurrent assets - current liabilities.
Goodwill and intangibles / assets38.9%(Goodwill + intangible assets) / total assets.
Tangible book value$320.8MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.48xRevenue / average total assets.
Fixed asset turnover42.7xRevenue / average property, plant and equipment.
Receivables turnover2.50xRevenue / average receivables.
Days sales outstanding146 days365 x average receivables / revenue.
Capex / operating cash flow9.1%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted-$0.19Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic-$0.19Net income per basic share, as reported (split-adjusted).
Revenue per share$10.45Revenue / diluted weighted shares.
FCF per share$0.91Free cash flow / diluted weighted shares.
Operating cash flow per share$1.00Cash from operations / diluted weighted shares.
Book value per share$17.32Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$8.22Tangible book value / shares outstanding.
Cash per share$6.18(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$337.8MShare price x shares outstanding.
Enterprise value$96.8MMarket cap + total debt - cash - short-term investments.
P/S0.77xMarket cap / revenue.
P/B0.50xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book1.05xMarket cap / tangible book value, when positive.
P/FCF8.86xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF8.06xMarket cap / cash from operations, when positive.
EV/Sales0.22xEnterprise value / revenue.
EV/EBITDA34.9xEnterprise value / EBITDA, when both are positive.
EV/FCF2.54xEnterprise value / free cash flow, when both are positive.
FCF yield11.3%Free cash flow / market cap.
Earnings yield-2.3%Net income / market cap (the inverse of P/E).
What was Perion Network Ltd.'s revenue in fiscal 2025?

Perion Network Ltd. reported revenue of $439.9M for fiscal 2025, 11.7% lower than the year before.

Was Perion Network Ltd. profitable in fiscal 2025?

No. It reported a net loss of $7.9M.

How much free cash flow did Perion Network Ltd. generate in fiscal 2025?

Cash from operations of $41.9M minus capital expenditures of $3.8M left free cash flow of $38.1M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Perion Network Ltd.